Ruxolitinib Is An Effective Treatment For Calr-Positive Patients With Myelofibrosis
BRITISH JOURNAL OF HAEMATOLOGY（2016）
Key words
myelofibrosis, CALR, ruxolitinib, JAK inhibitor, myeloproliferative neoplasm
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined